Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) is a biotechnology company focusing on various therapeutic fields. Analysts predict the company will break even in 2027, expecting a significant growth rate. The company's low debt ratio indicates prudent capital management.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing